Table 1 Benchmark Datasets Specifications.
Dataset | #Samples | #Features | Type | #Labels | Proportion of labels | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |||||
TOX\(\_\)171 | 171 | 5,748 | Biological | 4 | 26.3% | 26.3% | 22.8% | 24.6% | – | – | – | – | – | – |
SMK\(\_\)CAN\(\_\)187 | 187 | 19,993 | Biological | 2 | 48.1% | 51.9% | – | – | – | – | – | – | – | – |
Prostate\(\_\)GE | 102 | 5,966 | Biological | 2 | 49% | 51% | – | – | – | – | – | – | – | – |
lymphoma | 96 | 4,026 | Biological | 9 | 47.9% | 10.4% | 9.4% | 11.4% | 6.3% | 6.3% | 4.1% | 2.1% | 2.1% | – |
leukemia | 72 | 7,070 | Biological | 2 | 65.3% | 34.7% | – | – | – | – | – | – | – | – |
lung | 203 | 3,312 | Biological | 5 | 68.5% | 8.4% | 10.3% | 9.8% | 3% | – | – | – | – | – |
GLIOMA | 50 | 4,434 | Biological | 4 | 28% | 14% | 28% | 30% | – | – | – | – | – | – |
GLI\(\_\)85 | 85 | 22,283 | Biological | 2 | 30.6% | 69.4% | – | – | – | – | – | – | – | – |
CLL\(\_\)SUB\(\_\)111 | 111 | 11,340 | Biological | 3 | 9.9% | 44.1% | 46% | – | – | – | – | – | – | – |
ALLAML | 72 | 7,129 | Biological | 2 | 65.3% | 34.7% | – | – | – | – | – | – | – | – |
colon | 62 | 2,000 | Biological | 2 | 64.5% | 35.5% | – | – | – | – | – | – | – | – |
NCI9 | 60 | 9,712 | Biological | 9 | 15% | 15% | 13.3% | 8.3% | 11.7% | 10% | 13.3% | 10% | 3.33% | – |
pixraw10P | 100 | 10,000 | Image | 10 | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% |
warpAR10P | 130 | 2,400 | Image | 10 | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% |
warpPIE10P | 210 | 2,420 | Image | 10 | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% |
orlraws10P | 100 | 10,304 | Image | 10 | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% | 10% |
